Maarit J. Ahava
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 5
- SARS-CoV-2 detection and testing 5
- COVID-19 Clinical Research Studies 4
- Viral gastroenteritis research and epidemiology 1
-
- Immune responses and vaccinations 2
-
- Antibiotic Use and Resistance 2
-
- Zebrafish Biomedical Research Applications 2
-
- Advanced biosensing and bioanalysis techniques 3
- Co-authors
- Satu KurkelaMaija LappalainenOlli VapalahtiHanna JarvaAnne J. JääskeläinenSuvi KuivanenRaisa LoginovKaisa E. Oksanen
- Partner nations
- FinlandSwitzerland
In The Last Decade
Maarit J. Ahava
12 papers receiving 351 citations
Peers
Comparison fields: 5 of 55
- Infectious Diseases 281
- Immunology 79
- Applied Microbiology and Biotechnology 4
- Cell Biology 32
- Modeling and Simulation 8
Countries citing papers authored by Maarit J. Ahava
This map shows the geographic impact of Maarit J. Ahava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarit J. Ahava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarit J. Ahava more than expected).
Fields of papers citing papers by Maarit J. Ahava
This network shows the impact of papers produced by Maarit J. Ahava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarit J. Ahava. The network helps show where Maarit J. Ahava may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maarit J. Ahava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 29 | |
| 7 | 2021 | 46 | |
| 8 | 2021 | 22 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 123 | |
| 11 | 2017 | 22 | |
| 12 | 2015 | 17 | |
| 13 | 2013 | 58 |
About Maarit J. Ahava
Maarit J. Ahava is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Endocrinology, having authored 13 papers that have together received 358 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), SARS-CoV-2 detection and testing (5 papers), COVID-19 Clinical Research Studies (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), Antibiotic Use and Resistance (2 papers), Zebrafish Biomedical Research Applications (2 papers), Immune responses and vaccinations (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Infectious Diseases (281 citations), Immunology (79 citations) and Applied Microbiology and Biotechnology (4 citations). Maarit J. Ahava has collaborated with scholars based in Finland and Switzerland. Frequent co-authors include Satu Kurkela, Maija Lappalainen, Olli Vapalahti, Hanna Jarva, Anne J. Jääskeläinen, Suvi Kuivanen, Raisa Loginov, Kaisa E. Oksanen, Mataleena Parikka and Hannimari Kallio‐Kokko. Their work appears in journals such as PLoS ONE, Vaccine and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.